Guided Therapeutics (GTHP) Stock Price, News & Analysis

Company Overview

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Key Stats

• Today's Range: $0.28 to $0.28
• 50-Day Range: $0.14 to $0.30
• 52-Week Range: $0.06 to $0.32
• Volume: 1,251 shs
• Average Volume: 14,305 shs
• Market Capitalization: $22.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GTHP Stock Analysis - Frequently Asked Questions

How have GTHP shares performed this year?

Guided Therapeutics' stock was trading at $0.15 on January 1st, 2025. Since then, GTHP shares have increased by 86.7% and is now trading at $0.28.

How were Guided Therapeutics' earnings last quarter?

Guided Therapeutics Inc. (OTCMKTS:GTHP) issued its quarterly earnings data on Thursday, August, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $0.12 million during the quarter.

How do I buy shares of Guided Therapeutics?

Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Guided Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Guided Therapeutics investors own include Cornerstone Strategic Investment Fund (CLM), Intel (INTC), Beam Therapeutics (BEAM), ChargePoint (CHPT), CSX (CSX), Warner Bros. Discovery (DISCA) and Enbridge (ENB).

Company Calendar

• Last Earnings: 8/14/2025
• Today: 8/27/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:GTHP
• CIK: 924515
• Web: www.guidedinc.com
• Phone: (770) 242-8723
• Fax: 770-242-8639
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.42 million
• Net Margins: N/A
• Pretax Margin: -2,155.93%
• Return on Equity: N/A
• Return on Assets: -219.85%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.13
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: $10 thousand
• Price / Sales: 2,247.84
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.10) per share
• Price / Book: -2.80

Miscellaneous

• Outstanding Shares: 80,280,000
• Free Float: 26,630,000
• Market Cap: $22.48 million
• Optionable: Not Optionable
• Beta: 0.18